2C-B-FLY-NBOMe

Argentina treats 2C-B-FLY-NBOMe as an estupefaciente through the benzodifuran phenethylamine group in Annex II of Decree 560/2019. The compound's N-(2-methoxybenzyl) substitution falls within that group's permitted benzyl substituent bearing methoxy, and Article 2 applies control to substances captured by Annex II groups. Law 23.737 criminalizes unauthorized production, commerce, distribution, supply, and possession of estupefacientes.

Australia covers 2C-B-FLY-NBOMe through structural derivative and analogue provisions rather than an exact-name entry. The current Poisons Standard places 4-bromo-2,5-dimethoxyphenethylamine and Bromo-Dragonfly in Schedule 9, while section 7 makes each substance reference include every derivative; 2C-B-FLY-NBOMe is the N-(2-methoxybenzyl) FLY derivative. Separately, the Criminal Code border-control scheme lists 25-B-NBOMe and extends that listing to drug analogues, and the prohibited-imports regulations cover alkoxyphenylethylamines as a class.

2C-B-FLY-NBOMe falls within the NPSV phenethylamine group, which covers every compound derived from a phenethylamine basic structure and permits benzofuran-type ring systems and further substituents. The NPSG makes for-profit production, import, export, supply, or procurement for psychoactive human use an offence when the substance is covered by a class defined under § 3. The NPSG framework applies to new psychoactive substances and excludes substances already subject to the Suchtmittelgesetz.

2C-B-FLY-NBOMe is controlled in Brazil through Lista F2's generic phenethylamine class rather than by individual name. Its 1-phenylethan-2-amine core forms two dihydrofuran rings, bears a ring halogen, and carries a substituted benzyl group on nitrogen, all substitution patterns permitted by item d(1). Lista F is the Brazilian list of substances whose use is proscribed, with F2 covering psychotropic substances.

2C-B-FLY-NBOMe is covered by Canada’s Schedule III structural entry for 2C-phenethylamines, which covers a furan formed at adjacent benzene-ring carbons and permits benzyl substitution at the amino group, encompassing the FLY and NBOMe features. Possession without regulatory authorization is prohibited under the Act.

2C-B-FLY-NBOMe falls within the NpSG group of 2-phenethylamine-derived compounds: the Annex permits the relevant fused oxygen-containing ring system, bromine substitution, and an N-benzyl substituent with further permitted substitution. Section 2 defines a substance from an Annex 1 group as a new psychoactive substance. Section 3 prohibits trading, placing on the market, manufacturing, importing, exporting, acquiring, possessing, or administering such a substance, subject to its stated scientific, industrial, and official-use exceptions.

2C-B-FLY-NBOMe is covered by Lijst IA as a substance derived from 2-phenethylamine: its substituted tetrahydrobenzodifuran ring and N-(2-methoxybenzyl) aminoethyl side chain fit the schedule's permitted structural elements. Article 2a prohibits importing, exporting, preparing, processing, selling, supplying, transporting, possessing, and manufacturing a substance within a Lijst IA substance group or a preparation containing it. The statutory exceptions in Article 2a(2) apply to specified authorised medicinal, manufacturing, wholesale, veterinary, and precursor-control contexts.

Singapore's Misuse of Drugs Act 1973 covers an unlisted NPS when it has the capacity to produce a psychoactive effect; 2C-B-FLY-NBOMe is an NPS with strong psychedelic effects and measurable effects on brain and behaviour. Section 11I makes unauthorised possession and consumption of a psychoactive substance offences, while the Ministry of Home Affairs confirms that the effects-based framework also criminalises trafficking, manufacture, import and export. The framework preserves statutory exclusions and legitimate-purpose defences, so this classification concerns the compound's non-medical human use rather than every possible laboratory handling.

As of 23 August 2026, the current SAHPRA consolidation is dated 06 July 2026 and contains both Schedule 7 clause (vi) and the express entry '25B-NBOMe (2C-B-NBOMe)'. Clause (vi) defines covered homologues broadly as chemically related substances that incorporate a structural fragment similar to a listed substance and/or exhibit similar pharmacodynamic properties. 2C-B-Fly-NBOMe is 2-(8-bromo-2,3,6,7-tetrahydrobenzo[1,2-b:4,5-b’]difuran-4-yl)-N-(2-methoxybenzyl)ethan-1-amine, belongs to the N-benzylphenethylamine class, and has subnanomolar affinity and high activation efficacy at 5-HT2A. It therefore shares the brominated N-(2-methoxybenzyl)phenethylamine structural core and serotonergic pharmacology of the expressly listed 25B-NBOMe, satisfying the consolidation's disjunctive structural/pharmacodynamic definition. Section 22A(9) prohibits acquisition, use, possession, manufacture, or supply of a Schedule 7 substance without a Director-General permit, subject to the statutory authorization proviso. The date 06 July 2026 is the date of the current consolidation, not a separately established commencement date for this already-operative coverage. Government Notice 7445 of 8 May 2026 is an acupuncture scope-of-practice regulation under the Allied Health Professions Act, 1982, not a schedules amendment.

Controlled under the Misuse of Drugs Act 1971 through the N-benzylphenethylamine catch-all clause, which encompasses N-benzyl substituted phenethylamine derivatives.³⁹ Class A substances carry the most severe penalties under UK law.

Vermont lists 2CBFly-NBOMe by name as a hallucinogenic drug in § 7.0 of the Regulated Drug Rule. Under 18 V.S.A. §§ 4201 and 4235, it is a regulated drug in Vermont, where knowing unlawful possession and sale or dispensing are criminal offenses. This state-level restriction does not establish nationwide federal scheduling.